ImmunoGenesis
Houston
About ImmunoGenesis
ImmunoGenesis develops science-driven immune therapies specifically designed to treat tumors lacking activated T cells or having other immune resistance mechanisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $44.5M
- Last round: Grant (Dec 2025)
- Website: immunogenesis.com
- Phone: 346-772-0336
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/immunogenesis-26882 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.